Friday October 20 to Sunday October 22, 2023 Ottawa Ontario (venue to be confirmed) Draft Agenda Survey Please enable JavaScript in your browser to complete this form.Will you be interested in attending the Care Giver and Parent Conference… Read More
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome – Expanded agreement follows Acadia’s April 2023 U.S. launch of DAYBUE™ (trofinetide) as the first and only… Read More
Leave a Comment
Last Updated: 08/08/2023 by Steve
Survey – Parents and Caregivers Conference
Friday October 20 to Sunday October 22, 2023 Ottawa Ontario (venue to be confirmed) Draft Agenda Survey Please enable JavaScript in your browser to complete this form.Will you be interested in attending the Care Giver and Parent Conference… Read More
2023 Annual General Meeting
Leave a Comment
Last Updated: 08/24/2023 by admin
Acadia acquires global rights to Trofinetide
Leave a Comment
Last Updated: 08/28/2023 by admin
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome – Expanded agreement follows Acadia’s April 2023 U.S. launch of DAYBUE™ (trofinetide) as the first and only… Read More